Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval

News   Oct 25, 2016

 
Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval
 
 
 

RELATED ARTICLES

Biomarkers Could Produce Preeclampsia Diagnostic Test

News

Small non-coding RNA analysis may revolutionize how doctors assess preeclampsia risk.

READ MORE

Cancer Initiation Similar in Kidney, Liver, Stomach and Pancreas

News

Recent research has demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that this process may be universal; no matter the organ, when tissue responds to certain types of injury, mature cells seem to get younger and begin dividing rapidly, creating scenarios that can lead to cancer.

READ MORE

Ancient DNA Study Exposes Prehistoric Wanderlust

News

Extensive details about the migration and lives of prehistoric Europeans have been revealed by a huge new genomic study.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE